From: Associations between depression and different measures of obesity (BMI, WC, WHtR, WHR)
Total N = 4907-4970 3) | |
---|---|
% (N) | |
Sex, female | 49.1 (2438) |
Age, in years; mean (age-range 35–74) | 55.5 |
Partnership, yes | 82.4 (4093) |
SES, mean (± 1.96 SD) | 12.6 (3.9, 21.3) |
Depression (PHQ; > = cut-off of 10) | 7.2 (354) |
Total Score, median (Q1, Q3) | 3.0 (1.0, 6.0) |
Somatic-affective symptoms, median (Q1, Q3) | 2.0 (1.0, 3.0) |
Cognitive-affective symptoms, median (Q1, Q3) | 1.0 (0, 2.0) |
Smoking status, current | 19.2 (950) |
Physical activity, mean (± 1.96 SD) 2) | 7349.2 (−218.3, 14916.7) |
Alcohol (heavy use) | 28.4 (1407) |
Somatic conditions | |
Obesity (BMI > =30) | 24.2 (1204) |
BMI, mean (± 1.96 SD) | 27.3 (17.9, 36.6) |
Waist circumference (cm), mean (± 1.96 SD) | 93.9 (67.0, 120.7) |
WHtR, mean (± 1.96 SD) | 0.55 (0.40, 0.71) |
WHR, mean (± 1.96 SD) | 0.93 (0.74, 1.11) |
Hypertension | 51.5 (2558) |
Dyslipidemia | 29.4 (1460) |
Diabetes | 7.5 (371) |
Family history of myocardial infarction | 17.8 (883) |
Psychotropic medication | |
Non-selective monoamine reuptake inhibitors | 2.3 (113) |
Selective serotonin reuptake inhibitor | 1.7 (85) |
Other antidepressants | 1.1 (55) |
Antipsychotics | 0.7 (33) |
Anxiolytics | 1.1 (54) |
Hypnotics/sedatives | 1.3 (66) |
Antiepileptics | 1.2 (59) |
Opioids | 1.6 (80) |